BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
CYP51
,
nitric oxide metabolic process
,
Hepatitis
,
Prostate
,
Quercetin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antiviral agents
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
CXCL10
RSAD2
IFIT1
CXCL9
MX1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
NUYTTEN_EZH2_TARGETS_UP
response to stress
cytosol
response to organic substance
heterocyclic compound binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
IL-20 subfamily cytokines - effects on reconstituted human epidermis
Anti-FcgRIIb-treated dendritic cells and monocytes
IFN-gamma priming and IFN-gamma response in primary macrophages
Expression Profiles in Macrophages During Maturation and Polarization
M. tuberculosis sigma factor E effect in mouse macrophages
Explore Curated Studies Results
Literature
Most Relevant Literature
Paving new roads toward the advancement of broad-spectrum antiviral agents.
Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruse…
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents.
Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals.
Direct-acting Antivirals for Hepatitis C and Implication for Community Pharmacy Practice.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effects of Direct Antiviral Agents on Hepatitis C Virus Arthropathy
Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.
Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents
Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With …
Antiviral Agents Against COVID-19 Infection
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ